The burgeoning landscape of innovative treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a similar https://amaanilhz283020.wikigiogio.com/2000872/retatrutide_vs_tirzepatide_a_comparative_analysis